Pedia-lax Liquid
NDC Package 0132-0113-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Pedia-lax (docusate sodium) liquids is a medication used for a short time to treat occasional constipation. This formulation utilizes a liquid delivery system. Marketed by C.b. Fleet Company, Inc., this product is identified by NDC 0132-0113 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
0132-0113-24
Package Description
118 mL in 1 CARTON
Product Code
0132-0113
11-Digit Billing Format
00132011324
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pedia-lax
Non-Proprietary Name
Docusate Sodium
Substance Name
Docusate Sodium
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DOCUSATE SODIUM 50 mg/15mL
Usage Information
This medication is used for a short time to treat occasional constipation. It is a laxative (osmotic-type) that is thought to work by drawing water into the intestines, an effect that helps to cause movement of the intestines. This medication is also used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach.

Regulatory & Marketing

Labeler Name
C.b. Fleet Company, Inc.
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-28-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0132-0113-24 identifies a specific commercial package of 118 ml in 1 carton of Pedia-lax, a human over the counter drug labeled by C.b. Fleet Company, Inc.. This liquid is formulated for oral use and contains docusate sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by C.b. Fleet Company, Inc. on February 28, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used for a short time to treat occasional constipation. It is a laxative (osmotic-type) that is thought to work by drawing water into the intestines, an effect that helps to cause movement of the intestines. This medication is also used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach.

How is this C.b. Fleet Company, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00132011324. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0132-0113-24
11-Digit CMS (5-4-2)
00132-0113-24

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.